Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer

Cancer Letters

Volumn 231, Issue 2, 2006, Pages 169-175

  Chen, Jing ^a   Wu, Hua ^b   Han, Deyan ^a   Xie, Changsheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b No 1 Hospital of Xiamen   (China)

Author keywords

Liver cancer; Magnetic nanoparticles; Radioimmunotherapy

Indexed keywords

MONOCLONAL ANTIBODY I 131; NANOPARTICLE; SC 7269; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DISTRIBUTION; IMMUNOREACTIVITY; LEUKOCYTE COUNT; LIVER CANCER; MAGNETIC FIELD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME; TUMOR GROWTH; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; GENETIC VECTORS; HUMANS; IMMUNOCONJUGATES; IODINE RADIOISOTOPES; LEUKOCYTE COUNT; LIVER NEOPLASMS; MAGNETICS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOSTRUCTURES; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WEIGHT LOSS;

ANIMALIA; MUS MUSCULUS;

EID: 29844446910     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.024     Document Type: Article

References (11)

1. S.J. Cheng, and Y.M. Yu Experimental Nuclear Medicine 1999 Chongqing University Press Chongqing pp. 43-62
2. P.R.P. Salacinski, C. McLean, J.E. Sykes, W. Clement-Jones, and P.J. Lowry Iodination of proteins, glycoproteins, and pepides using iodogen Anal. Biochem. 117 1981 136 140
3. T. Lindmo, E. Boven, F. Cuttitta, J. Fedorko, and P.A. Bunn Jr Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess J. Immun. Med. 72 1984 77 89
4. K. Shimoda, M. Mori, K. Shibuta, B.F. Banner, and G.F. Barnard Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma Int. J. Oncol. 14 1999 353 359
5. R. Yamaguchi, H. Yano, A. Iemura, S. Ogasawara, M. Haramaki, and M. Kojiro Expression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 1998 68 77
6. A. Christoph, A. Wolfgang, J.K. Roswitha, G.P. Fritz, H. Peter, and B. Christian Locoregional cancer treatment with magnetic drug targeting Cancer Res. 60 2000 6641 6648
7. K.X. Tao, D.D. Chen, Z.D. Wu, Y. Tian, X.M. Lu, and X.P. Yang The clinic research on the treatment of gastric cancer using the adriamycin magnetic albumin microspheres before operation Chin. J. Gen. Surg. 16 2001 255 258
8. 131I-labeled anti-VEGF monoclonal antibody in nude micebearing human bladder cancer ACTA Academiae Medicinae Militaris Tertiae 24 2002 167 169
9. 131I - chTNTin nude mice with human hepatoma Chin. J. Nucl. Med. 18 1998 215 216
10. G.L. Griffiths, D.M. Goldenberg, F.F. Knapp Jr, A.P. Callahan, C.H. Chang, and H.J. Hansen Direct radiolabeling of monoclonal antibodies with generator-produced Rhenium188 for radioimmunotherapy: labeling and animal biodistribution studies Cancer Res. 51 1991 4594 4602
11. J. Chang Adriamycin - loaded immunological magnetic nanoparticles: site-specific targeting of the nanoparticles in rabbits guided by an outside magnetic field Chin. J. Biomed. Eng. 15 1996 354 357